The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Roche’s new Hepatitis B test brings a higher level of specificity to viral load detection. For those with chronic Hepatitis B, this improvement in patient monitoring favorably impacts their therapeutic outcome.
Continue reading »A six-month follow-up to Intercell's Phase II trial of their Hepatitis C vaccine with a topical toll-like receptor agonist showed a significant reduction in viral load. While data from two weeks after the vaccination series showed promise, participants with Hepatitis C genotype 1 had viral loads that continued to decline six months after treatment.
Continue reading »California scientists have found that an old antihistamine drastically reduces Hepatitis C viral replication.
Continue reading »Learn about the facts on pegylated interferon alfa-2a and pegylated interferon alfa-2b, the standard treatment for chronic Hepatitis C. Comparing and contrasting the pegylated interferons may help better explain a physician’s preference or indifference between the two when treating his or her Hepatitis C patients.
Continue reading »Hundreds of non-responders to interferon-ribavirin combination therapy will be enrolled in a late stage clinical trial for Vertex's telaprevir.
Continue reading »Although a large-scale study concluded long-term interferon therapy to be ineffectual for Hepatitis C management, it demonstrated improvements in quality of life for participants supplementing with silymarin.
Continue reading »Currently approved treatment for chronic Hepatitis C is about 50 percent effective. New research from Canada claims that early treatment boosts its effectiveness up to 90 percent.
Continue reading »Successful animal studies have paved the way for a human trial to determine if warfarin prevents liver damage in those with Hepatitis C.
Continue reading »Whether added to standard combination therapy or as a monotherapy, studies show that R1626 is a powerful HCV anti-viral medicine.
Continue reading »Diet and exercise are often quoted as the solution to most of our modern health problems. For reducing the risk of developing liver cancer, new research shows that these lifestyle changes are crucial to people with chronic Hepatitis C.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
